Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
---|
03/04/1998 | EP0826052A1 High molecular weight major outer membrane protein of moraxella |
03/04/1998 | EP0826051A1 Botulinum toxin derivatives able to modify peripheral sensory afferent functions |
03/04/1998 | EP0826050A1 Modified polypeptides for enhanced immunogenicity |
03/04/1998 | EP0826049A1 Human interferon tau compositions and methods of use |
03/04/1998 | EP0826048A1 Pancreas-derived serpin |
03/04/1998 | EP0826047A1 Recombinant baculovirus insecticides |
03/04/1998 | EP0826045A1 Nucleic acids for treating obesity |
03/04/1998 | EP0826044A1 Bmp-15 compositions |
03/04/1998 | EP0826043A1 Methods for modulating t cell survival by modulating bcl-x l? protein level |
03/04/1998 | EP0826042A2 Genetic sequences and proteins related to alzheimer's disease, and uses therefor |
03/04/1998 | EP0826041A1 Transforming growth factor alpha hii |
03/04/1998 | EP0826039A1 Method of inhibiting the activity of an intracellular constituent |
03/04/1998 | EP0826038A2 Soluble, active hepatitis c virus protease |
03/04/1998 | EP0826035A1 Isolating and culturing schwann cells |
03/04/1998 | EP0826034A1 Generation of large genomic dna deletions |
03/04/1998 | EP0826033A1 Ataxia-telangiectasia gene |
03/04/1998 | EP0826031A1 Ataxia-telangiectasia gene and its genomic organization |
03/04/1998 | EP0826006A1 Transeptithelial transport of molecular species |
03/04/1998 | EP0826002A2 Biologically active peptide fragments of ob protein |
03/04/1998 | EP0825997A1 Identification of enantiomeric ligands |
03/04/1998 | EP0825996A1 Fibroblast growth factor homologous factor-1 (fhf-1) and methods of use |
03/04/1998 | EP0825878A1 Composition and method for tumor imaging |
03/04/1998 | EP0825875A1 Therapeutic composition comprising an antigen or an in vivo generator for generating a compound comprising an amino acid sequence |
03/04/1998 | EP0825811A1 Non-genetically modified mammal as a model for multiple sclerosis |
03/04/1998 | EP0662129B1 Cloning and sequencing of allergens of dermatophagoides (house dust mite) |
03/04/1998 | EP0656121B1 Method for diagnosing and monitoring sepsis |
03/04/1998 | EP0644948B1 Anti-receptor antibodies to the vitamin b12/transcobalamin ii receptor |
03/04/1998 | EP0554389B1 Molecular clones of hiv-1 and uses thereof |
03/04/1998 | EP0390799B1 Respiratory syncytial virus: vaccines |
03/04/1998 | CN1175283A Method and apparatus for DNA identification |
03/04/1998 | CN1175282A An apparatus for performing magnetic cycle reaction |
03/04/1998 | CN1175281A Synthesis of stereospecific oligonucleotide phosphorothioates |
03/04/1998 | CN1175280A Novel lysine decarboxylase gene and process for producing L-lysine |
03/04/1998 | CN1175263A Recombinant IL-5 antagonists useful in treatment of IL-5 mediated disorders |
03/04/1998 | CN1174889A Fibrinolysin generated from streptomycin |
03/04/1998 | CN1174852A Structured copolymers used as absorbents, gels and carriers of metal ions |
03/03/1998 | US5723766 Control of fruit ripening through genetic control of ACC synthase synthesis |
03/03/1998 | US5723765 Control of plant gene expression |
03/03/1998 | US5723764 Genetic engineering |
03/03/1998 | US5723763 Plants with modified flowers |
03/03/1998 | US5723762 Transgenic plants expressing a prokaryotic ammonium dependent asparagine synthetase |
03/03/1998 | US5723761 Plant acyl-ACP thioesterase sequences |
03/03/1998 | US5723760 Genetic engineering |
03/03/1998 | US5723759 Pyrrolnitrin biosynthesis genes |
03/03/1998 | US5723757 Plant promoters specific for sink organ expression of genes |
03/03/1998 | US5723756 Genetic engineering |
03/03/1998 | US5723755 Biosynthesis |
03/03/1998 | US5723754 Tapetum-specific promoters from Brassicaceae spp |
03/03/1998 | US5723752 Genetic engineering |
03/03/1998 | US5723751 Expression motifs that confer tissue and development-specific expression in plants |
03/03/1998 | US5723750 Viricides, genetic engineering |
03/03/1998 | US5723747 Wax esters in transformed plants |
03/03/1998 | US5723746 Reduced ethylene synthesis and delayed fruit ripening in transgenic tomatoes expressing S-adenosylmethionine hydrolase |
03/03/1998 | US5723719 Transgenic mouse as model for diseases involving dopaminergic dysfunction |
03/03/1998 | US5723598 Encoded combinatorial chemical libraries |
03/03/1998 | US5723595 Dna sequence codes and enzymes |
03/03/1998 | US5723594 High affinity PDGF nucleic acid ligands |
03/03/1998 | US5723592 Evolution of products from nucleic acids |
03/03/1998 | US5723591 Self-quenching fluorescence probe |
03/03/1998 | US5723588 Heat stable resin with polypeptides such as elastin, collagen with keratin or silk proteins |
03/03/1998 | US5723585 Method of purifying cardiac hypertrophy factor |
03/03/1998 | US5723584 Polypeptides and dna for genetic engineering |
03/03/1998 | US5723583 Antibody containing sialyl lewis X determinants |
03/03/1998 | US5723581 Murine and human box-dependent myc-interacting protein (Bin1) |
03/03/1998 | US5723441 Method of treating renal disease by administering IGF-I and IGFBP-3 |
03/03/1998 | US5723440 Insecticides and pesticides |
03/03/1998 | US5723438 Administering the soluble antiviral domain of the ldl receptor protein of seq id no:2 or a salt, derivative or mutant thereof |
03/03/1998 | US5723437 Glycoproteins and cell surfaces and scavenger receptors |
03/03/1998 | US5723436 Immunosuppressants |
03/03/1998 | US5723343 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
03/03/1998 | US5723335 Immune stimulation by phosphorothioate oligonucleotide analogs |
03/03/1998 | US5723333 Vectors of oncogenes, promoters, transcription |
03/03/1998 | US5723332 Translational enhancer DNA |
03/03/1998 | US5723330 Genetically engineered reporter bacteria for the detection of bacteriophage |
03/03/1998 | US5723329 DNA encoding retinoid receptor X (RXR) alpha and gamma; corresponding vectors and host cells |
03/03/1998 | US5723328 Enzyme with endoglucanase activity |
03/03/1998 | US5723326 Genome coding phytolacca antiviral protein and a recombinant expression vector therefor |
03/03/1998 | US5723324 Apparatus and method for electrostatic endothelial cell seeding and DNA transfection in a vascular prosthesis |
03/03/1998 | US5723323 Method of identifying a stochastically-generated peptide, polypeptide, or protein having ligand binding property and compositions thereof |
03/03/1998 | US5723319 Cultured cell line that inducibly expresses the hepatitis B virus genome, and uses thereof for screening antiviral substances |
03/03/1998 | US5723318 DNA coding for megakaryocyte potentiator |
03/03/1998 | US5723316 α-1-antichymotrypsin analogues having chymase inhibiting activity |
03/03/1998 | US5723315 Secreted proteins and polynucleotides encoding them |
03/03/1998 | US5723314 Antigens and antibodies and peptides |
03/03/1998 | US5723313 ARF-p19, a novel regulator of the mammalian cell cycle |
03/03/1998 | US5723310 Aqueous multiple-phase isolation of polypeptide |
03/03/1998 | US5723309 Production of subunits of soluble T cell receptors by co-transfection |
03/03/1998 | US5723303 Immunoglobulin a binding protein |
03/03/1998 | US5723299 Somatostatin receptors |
03/03/1998 | US5723296 Amplification and detection of mycobacterial DNA K nucleic acids |
03/03/1998 | US5723293 Diagnostic method and kit for determining Rh blood group genotype |
03/03/1998 | US5723292 Stable DNA constructs |
03/03/1998 | US5723291 Methods for screening compounds for estrogenic activity |
03/03/1998 | US5723290 Methods for profiling mRNA expression in neurites |
03/03/1998 | US5723289 Parallel selex |
03/03/1998 | US5723287 Retroviral particle comprising fusion protein and nucleic acid; genetic engineering |
03/03/1998 | US5723286 Peptide library and screening systems |
03/03/1998 | US5723129 GnRH-leukotoxin chimeras |
03/03/1998 | US5723125 Hybrid with interferon-alpha and an immunoglobulin Fc linked through a non-immunogenic peptide |
03/03/1998 | US5723120 Method of treating an IL-6 related disease with interleukin-6 receptor antagonists |